Morgan Stanley Roivant Sciences Ltd. Put Options Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$844 Million5.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$554 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$498 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$482 Million1.22% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$414 Million32.33% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $9.92B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...